126 related articles for article (PubMed ID: 3873985)
21. Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Cancer; 1988 Apr; 61(7):1304-11. PubMed ID: 3125957
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
Bacci G; Ferrari S; Delepine N; Bertoni F; Picci P; Mercuri M; Bacchini P; Brach del Prever A; Tienghi A; Comandone A; Campanacci M
J Clin Oncol; 1998 Feb; 16(2):658-63. PubMed ID: 9469355
[TBL] [Abstract][Full Text] [Related]
23. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
[TBL] [Abstract][Full Text] [Related]
24. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
25. Osteosarcoma: review of the past, impact on the future. The American experience.
Jaffe N
Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
[TBL] [Abstract][Full Text] [Related]
26. Hyperthermic isolated perfusion using cisplatin for treatment of the extremities.
Takeyama S; Tateishi A; Higaki S; Yamanashi M
Cancer Treat Res; 1993; 62():235-40. PubMed ID: 8096738
[No Abstract] [Full Text] [Related]
27. Experimental studies on high-dose methotrexate with citrovorum factor chemotherapy for 89Sr-induced osteosarcoma murine model.
Tomita K
Jpn J Antibiot; 1986 May; 39(5):1219-27. PubMed ID: 3489843
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.
Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M
J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results.
Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A
Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534
[TBL] [Abstract][Full Text] [Related]
30. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
31. [Intra-arterial neoadjuvant chemotherapy of sarcoma of the extremities].
Graziani G; Priori T; Fiorentini G; Molinari M; Tienghi A
Radiol Med; 1990 Oct; 80(4):474-6. PubMed ID: 2173854
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
Bacci G; Avella M; Capanna R; Boriani S; Dallari D; Galletti S; Giunti A; Madon E; Mancini A; Mercuri M
Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324
[TBL] [Abstract][Full Text] [Related]
33. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
34. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
36. Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized study.
Bacci G; Ruggieri P; Picci P; Mercuri M; Ferraro A; Tella G; Ferrari S; Bertoni F; Comandone A
J Chemother; 1996 Feb; 8(1):70-81. PubMed ID: 8835114
[TBL] [Abstract][Full Text] [Related]
37. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
[TBL] [Abstract][Full Text] [Related]
38. [Postoperative adjuvant chemotherapy of high dose MTX for osteogenic sarcoma].
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):233-5. PubMed ID: 3265374
[TBL] [Abstract][Full Text] [Related]
39. [Neoadjuvant chemotherapy for osteosarcoma].
Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
[TBL] [Abstract][Full Text] [Related]
40. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
Cohen IJ
Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
